Does Wegovy thin your hair — and what does the evidence say?

What the STEP 1 trial data recorded about hair loss

The STEP 1 trial (the pivotal 68-week study of semaglutide 2.4mg that underpins Wegovy's UK licence) enrolled 1,961 adults and measured a wide range of adverse events. Hair loss appeared in the data, but it ranked well below the gastrointestinal effects (nausea, diarrhoea, constipation) that dominate the side-effect picture. The STEP 1 paper, published in the New England Journal of Medicine, recorded alopecia in around 3% of participants on semaglutide versus around 1% on placebo, a real signal, but a modest one. Knowing that figure exists is useful; so is knowing that the trial also tracked participants through a 12-week treatment-free period, and that hair-related complaints did not persist as a major ongoing concern.

The NHS medicines guidance for semaglutide lists hair loss under less common effects (meaning it affects somewhere between 1 in 100 and 1 in 1,000 people) rather than under the common or very common categories. That framing matters: it is worth monitoring, but it is not inevitable.

Why rapid weight loss, not the drug itself, is usually the real trigger

Telogen effluvium is the medical term for the temporary shedding that occurs when the body experiences a significant physiological stress. Rapid calorie restriction qualifies. When energy intake drops sharply, the body quietly reroutes resources away from non-essential processes, and hair follicle cycling is near the top of that deprioritisation list. Follicles shift from the active growth phase (anagen) into the resting phase (telogen) earlier than usual, and three to four months later (because that is the natural lag between follicle stress and visible shedding) hair starts coming out in larger-than-normal clumps.

This pattern is well documented after bariatric surgery, very-low-calorie diets and any illness involving rapid unintentional weight loss. Semaglutide suppresses appetite effectively, which means some people inadvertently under-eat by more than their prescriber intended. The drug itself is not stripping follicles; it is the downstream nutritional consequence that matters. You can read more about the broader side-effect picture on our guide to hair thinning on Wegovy.

Protein is the nutrient most directly implicated. Hair is almost entirely keratin, a protein, and when total intake is low, structural proteins are among the first sacrificed. Aiming for adequate daily protein (the exact amount depends on your body weight and should be discussed with your prescriber or a dietitian) is the single most evidence-backed protective step.

Timescale and what recovery usually looks like

Most people who experience telogen effluvium after starting a GLP-1 medicine see shedding peak at around the three-to-five-month mark. By the time weight stabilises and nutritional intake normalises, regrowth typically follows within a similar window, and our dedicated guide to Wegovy and hair walks through what that recovery period tends to look like in practice. The NHS patient information for semaglutide advises telling your doctor or pharmacist if you notice hair loss, which is the right starting point: ruling out other causes (thyroid changes, iron deficiency, unrelated dermatological conditions) is important before attributing everything to the medicine.

A full blood panel at the point of noticing shedding is sensible. Ferritin (stored iron), thyroid function, and vitamin D are worth checking because they are independently common causes of hair thinning in adults and can coexist with weight-loss treatment. Worth checking, if levels come back low, supplementing appropriately can accelerate recovery.

If hair loss is severe, patchy rather than diffuse, or accompanied by scalp changes, a GP or dermatologist should assess rather than waiting to see whether it settles. That is a different clinical picture from the typical telogen effluvium described here.

Practical steps while you are on treatment

The guidance is not complicated, though it does require some attention to daily habits. Prioritise protein at each meal (eggs, fish, legumes, Greek yoghurt) rather than letting appetite suppression make every meal a token affair. Stay well hydrated. Avoid adding further physiological stress: very aggressive calorie targets, crash restriction on top of the medicine's effects, or skipping meals entirely all increase the likelihood of nutritional shortfalls.

If you are mid-cycle on a dose increase when the shedding starts, note the timing and mention it at your next clinical review. Dose progression is titrated by your prescriber for exactly this reason, the pace of weight loss and tolerability both feed into the decision. Thinking about the 12pm order cut-off when planning around holidays or a busy patch at work is the kind of practical detail our prescribers factor in too; continuity of care through stable, supported treatment reduces the boom-and-bust calorie pattern most associated with this type of hair loss.

For a broader look at how semaglutide works and what the treatment journey involves, our Wegovy overview covers the full picture. And if you want to understand how the cost of private treatment fits into the decision, our Wegovy price comparison page sets out what a transparent, all-included price actually means in practice. Our semaglutide information page goes deeper on the clinical evidence if you want to read further before deciding anything, including a section on whether semaglutide thins your blood, a question that comes up more often than you might expect.

Wegovy is a prescription-only medicine. Whether it is right for you depends on your full medical history, which a clinician needs to assess. If you have questions about hair loss specifically, that is exactly the kind of concern our prescribers want to hear about at consultation, it shapes how they support you through the first few months of treatment. Start your free consultation and a GPhC-registered prescriber will review your case the same day.